John W Davies1, Meir Glick, Jeremy L Jenkins
1Lead Discovery Center, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, MA 02139, USA. john-w.davies@novartis.com
High Throughput Screening (HTS) is expensive, costing up to $1 million per million compounds. In silico screening offers a cost-effective solution for faster and more efficient drug lead discovery.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: